Common Pitfalls in Structuring Non-Dilutive Financings Using Licenses or Collaborations

Life sciences companies, especially innovative biotechs, rely heavily on external funding to finance operations, in particular R&D.  Amid market turbulence, these companies are increasingly seeking alternative sources of financing through strategic licensing and partnerships. In this webcast recorded at the Jefferies London Healthcare Conference, Healthcare & Life Sciences partners Eveline Van Keymeulen and Robbie McLaren with associates Oliver Mobasser and Sam Peacock identify some common pitfalls and challenges when structuring those agreements.